Value £6,482,400

GlycanAge

VC Funding

Series A

Healthcare & Biotech Published 19 December 2025

Summary

In a significant market movement during December 2025, GlycanAge was the subject of a vc funding. The transaction achieved a gross valuation of £6,482,400. Leading the round was Fifth Quarter Ventures, Vesna Deep Tech VC, South Central Ventures, Guinness Ventures, Impetus Capital, BrightCap Ventures, Lightfield Equity.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Fifth Quarter Ventures

Lead Investor / Acquirer

Vesna Deep Tech VC

Lead Investor / Acquirer

South Central Ventures

Lead Investor / Acquirer

Guinness Ventures

Lead Investor / Acquirer

Impetus Capital

Lead Investor / Acquirer

BrightCap Ventures

Lead Investor / Acquirer

Lightfield Equity

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series A prioritised

VC Funding

Newcells Biotech

£2,350,000

Feb 2024

VC Funding

HutanBio

£2,250,000

Jan 2024

VC Funding

Lottie

£17,253,062

Oct 2023

VC Funding

Skin Analytics

£4,000,000

Sept 2020

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.